ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 117 filers reported holding ANAPTYSBIO INC in Q1 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $2,642,000 | +58.1% | 118,261 | 0.0% | 0.10% | +32.9% |
Q1 2020 | $1,671,000 | -13.1% | 118,261 | 0.0% | 0.08% | +4.1% |
Q4 2019 | $1,922,000 | -18.6% | 118,261 | +75.2% | 0.07% | -29.1% |
Q3 2019 | $2,362,000 | -44.0% | 67,496 | -9.8% | 0.10% | -40.1% |
Q2 2019 | $4,220,000 | -12.3% | 74,798 | +13.6% | 0.17% | -11.8% |
Q1 2019 | $4,810,000 | +14.5% | 65,845 | 0.0% | 0.20% | +8.3% |
Q4 2018 | $4,200,000 | -8.3% | 65,845 | +43.4% | 0.18% | +8.4% |
Q3 2018 | $4,580,000 | – | 45,910 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |